GFBiochemicals

About us

GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.

In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for this revolution in chemicals and biofuels.

GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.

With production at Caserta to be scaled up to 10,000 MT/a by 2017, GFBiochemicals expects substantial growth in the levulinic acid market coming years. Our team of technical experts have decades of experience in innovation, production and business development. Funded and supported by private investors, GFBiochemicals is committed for the long-term.

Contact us now for sample requests or to discuss partnership opportunities..

Our Mission

GFBiochemicals is bringing biobased levulinic acid to market through technology innovation. Levulinic acid is a platform chemical with significant potential to replace petroleum-based products in the chemical and biofuel sectors. GFBiochemicals has proprietary technology and a commercial-scale plant in Caserta, Italy.

Our Vision

Our proprietary technology portfolio and experience makes GFBiochemicals a leader in the field. Customers tap into the potential of a unique chemical portfolio, based on levulinic acid. This approach will further enable new applications for versatile chemical platform products, which we support with in-house process development, production and commercialization.

Clear need for new sustainable chemical building blocks

Societal challenge today

  • "Blacklisted" solvents
  • Phtalate plasticizers in marine life
  • Use of bisphenol A
  • Diluted and fossil-based detergents
  • Fuels causing air pollution
  • Biofuels from vegetable oils

Solution with levulinic acid

  • Green solvents
  • Biodegradable plasticizers for flexible PVC
  • Epoxy resins based on diphenolic acid
  • Highly concentrated biobased detergents
  • Clean-burning fuels and fuel components
  • Fuels derived from cellulosic biomass waste

Focused on levulinic acid production since 2008

Foundation
Mission: Bringing levulinic acid to the market by technology innovation
2008
Facility
Lease Caserta plant to develop and demo breakthrough technologies
2009
New funds
New investor and rebranding Green Future to GFBiochemicals
2013
Organisation
Key personnel from global leaders enforce GFBiochemicals to further develop the technologies
2014
Plant Start-up
Commercial production of levulinic acid starts July 2015
2015
GFBiochemicals Americas
Acquisition of Segetis assets, IP and trademarks
2016
Capacity
Capacity increases to 10,000 MT
2017
Expansion
New world-scale facility increasing capacity to 50,000 MT
2019

Caserta production plant: innovation and R&D

Levulinic acid produced by GFBiochemicals' technology is sourced from abundant renewable feedstocks. Given GFBiochemicals' flexibility in inputs, biomass from a variety of sources can be converted.

GFBiochemicals also plans to expand its product portfolio to additional high-value levulinic acid derivatives. The derivatives will be developed at the company’s Caserta production site to accelerate downstream market introduction.

GFBiochemicals' staff and technical experts have decades of experience in innovation, production and business development. Funded and supported by private investors, GFBiochemicals is committed for the long-term.

Our team

  • Maxim Katinov
    Chief Executive Officer
    With over 20 years of experience in finance renewable energy, Maxim has led projects from business incubation to full business development. With a combination of science and business backgrounds, he is an adept entrepreneur, executive and investor.
  • Marcel van Berkel
    Chief Commercial Officer
    Marcel is a business leader driven by a passion for growth and innovation in the bioeconomy. Marcel has more than 25 years of international experience as a business executive, at companies such as DSM and Solvay. He has a solid track record in bringing businesses to the next level of growth via strategic alliances.
  • Rudy Parton
    Director Technology & Applications Development
    Rudy spearheads research and development at GFBiochemicals, previously working as a project leader and principle scientist at DSM. With over 25 years of research experience in academia as well as the private sector, he is an extraordinarily creative R&D professional.
  • Aris de Rijke
    Director Technology & Engineering
    As an outstanding chemical engineering professional with deep technical knowledge, Aris is committed to the development of biobased alternatives. With over 15 years of chemical technology know-how gathered at DSM, Shell and Norsk Hydro, he now oversees levulinic acid technology.
  • Davide Gremmi
    Chief Financial Officer
    With more than 20 years of finance experience in the bioeconomy and other sectors, Davide brings a diverse background to GFBiochemicals. His previous roles include CFO at Chemtex Group. Davide focuses on internal and international growth and M&A.
  • Marcello Taglietti
    Chief Operating Officer
    Marcello has worked in leading chemical companies such as KMG Chemicals Inc, Air Products and Chemicals and Ashland, Inc. for over 20 years. His elaborate operations experience makes him an accomplished manager of production and distribution, capital project management and ISO implementation.